top of page
NEXJENNER
About Us
Business Network
Adviser Group
Certificate·Patent
SERVICE
Drug Structural Design
Chemical Compound Pharmaceutical
ADC
CAR-T & CAR-NK
NK Cell Therapy
Inactivated Vaccine
Drug Efficacy Analysis and Production
BGMP API Production
Physical and Chemical Analysis Test
Genomic Analysis Test
Non-clinical Test (in-vitro)
Non-clinical Test (in-vivo)
DDS and Formulation
Documentation and Licensing Support
DDS Types
Brain-delivered DDS Formulation
Formulation-Injection
Formulation-Oral Liquid
CMC/DMF & CTD Support
Pharmaceuticals Support
Medical Devices Support
Combination Product Support
Formulation-Soft Capsule
Vaccine Adjuvant
IR
Technology Transfer Partner Company
New Drug Development Pipeline
General Research Pipeline
Nexjenner [New Drug, General Research]
Items Available for Technology Transfer
Nexjenner New Drug Development Pipeline
Nexjenner General Research Pipeline
Partner Organizations
Advanced Medical Bio Research Institute
Demonstration Research Institute
Advanced Medical Product Licensing
Product Promotion Support Center
Ajou University Convergence Medical
Entrepreneurs Association
Korea Science and Technology
Korea Technology Finance Corporatio
Daegu-Gyeongbuk Tech Holdings, Inc.
SCIENCE NEWS
SCIENCE NEWS
Bioscience
Drug Discovery & Development
Digital Health
Sustainability-ESG
AI & Future Tech
CONTACT US
KOR
NEXJENNER
SCIENCE NEWS
SCIENCE NEWS
Bioscience
Drug Discovery & Development
Digital Health
Sustainability-ESG
AI & Future Tech
폐에서 암세포 전이(Metastase)가 자주 발생하는 이유
암 환자의 경우 특히 폐에서 전이가 발생하는 경우가 많다. 그 이유 중 하나는 폐에서 흔히 발견되는 아미노산 아스파르트산염이며, 생의학 과학자들이 발견한 바와 같이 복잡한 메커니즘을 통해 암세포가 쉽게 정착할 수 있도록 해준다.
Sustainability-ESG
TOP
bottom of page